LaminaGastrodin ameliorates Parkinson's disease by downregulating connexin 43

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 585-590

  Wang, Yu ^a   Wu, Zhe ^a   Liu, Xu ^a   Fu, Qunying ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Connexin 43; Gap junctional intercellular communication; Gastrodin; Parkinson's disease model; Rotenone

Indexed keywords

CONNEXIN 43; GASTRODIN; ROTENONE; BENZYL ALCOHOL DERIVATIVE; GLUCOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GAP JUNCTION; HIPPOCAMPUS; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; WESTERN BLOTTING; ANIMAL; ASTROCYTE; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; DRUG EFFECTS;

RATTUS;

ANIMALS; ASTROCYTES; BENZYL ALCOHOLS; CELL COMMUNICATION; CONNEXIN 43; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GAP JUNCTIONS; GENE EXPRESSION REGULATION; GLUCOSIDES; PARKINSON DISEASE; PHOSPHORYLATION; RATS; ROTENONE;

EID: 84879934374     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1535     Document Type: Article

References (36)

1. Paisán-Ruíz C, Jain S, Evans EW, et al: Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600, 2004.
2. Zhang X, Lu L, Liu S, Ye W, Wu J and Zhang X: Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson's disease. Int J Biochem Cell Biol 45: 265-272, 2013.
3. Salama M, Ellaithy A, Helmy B, et al: Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. CNS Neurol Disord Drug Targets 11: 836-843, 2012.
4. Ahn EH, Kim DW, Shin MJ, et al: PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model. Free Radic Biol Med 55: 36-45, 2013.
5. Tönges L, Frank T, Tatenhorst L, et al: Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease. Brain 135: 3355-3370, 2012.
6. Ali F, Stott SR and Barker RA: Stem cells and the treatment of Parkinson's disease. Exp Neurol: Jan 6, 2013 (Epub ahead of print).
7. Nishimura K and Takahashi J: Therapeutic application of stem cell technology toward the treatment of Parkinson's disease. Biol Pharm Bull 36: 171-175, 2013.
8. Kim H: Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurol Res 27: 287-301, 2005.
9. Pearl PL, Drillings IM and Conry JA: Herbs in epilepsy: evidence for efficacy, toxicity, and interactions. Semin Pediatr Neurol 18: 203-208, 2011.
10. Schachter SC: Botanicals and herbs: a traditional approach to treating epilepsy. Neurotherapeutics 6: 415-420, 2009.
11. Manavalan A, Ramachandran U, Sundaramurthi H, et al: Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities. Int J Biochem Mol Biol 3: 219-241, 2012.
12. Li C, Chen X, Zhang N, Song Y and Mu Y: Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats. Neural Regen Res 7: 325-331, 2012 (In Chinese).
13. Karuppagounder SS, Madathil KS, Pandey M, Haobam R, Rajamma U and Mohanakumar KP: Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats. Neuroscience 236: 136-148, 2013.
14. Xiong N, Long X, Xiong J, et al: Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models. Crit Rev Toxicol 42: 613-632, 2012.
15. Drinkut A, Tereshchenko Y, Schulz JB, Bähr M and Kügler S: Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery. Mol Ther 20: 534-543, 2012.
16. Hauser DN and Cookson MR: Astrocytes in Parkinson's disease and DJ-1. J Neurochem 117: 357-358, 2011.
17. Rappold PM and Tieu K: Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 7: 413-423, 2010.
18. Rouach N and Giaume C: Connexins and gap junctional communication in astrocytes are targets for neuroglial interaction. Prog Brain Res 132: 203-214, 2001.
19. Dermietzel R, Gao Y, Scemes E, et al: Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res Brain Res Rev 32: 45-56, 2000.
20. Nagy JI and Rash JE: Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 32: 29-44, 2000.
21. Thompson RJ and Macvicar BA: Connexin and pannexin hemichannels of neurons and astrocytes. Channels (Austin) 2: 81-86, 2008.
22. Li X and Simard JM: Multiple connexins form gap junction channels in rat basilar artery smooth muscle cells. Circ Res 84: 1277-1284, 1999.
23. Kawasaki A, Hayashi T, Nakachi K, et al: Modulation of connexin 43 in rotenone-induced model of Parkinson's disease. Neuroscience 160: 61-68, 2009.
24. Ya-qin C, Yi-fan S, Hong C, Jian-ping W and Jiao D: Effects of gastrodin on Cx43 expression in temporal lobe cortex and hippocampus of pentylenetetrazole-induced epileptic immature rats. Journal of Lanzhou University (Medical Sciences) 34: 9, 2008.
25. Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D and Dowd E: The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats. Behav Brain Res 243: 6-15, 2013.
26. Thakur P and Nehru B: Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease. Neuroscience 231: 420-431, 2013.
27. Care IoLARCo, Animals UoL and Resources NIoHDoR: Guide for the care and use of laboratory animals. US Department of Health and Human Services, Public Health Service, National Insititutes of Health, 1985.
28. Wisniewska-Kruk J, Hoeben KA, Vogels IM, et al: A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes. Exp Eye Res 96: 181-190, 2012.
29. Takizawa T, Gudla PR, Guo L, Lockett S and Misteli T: Allele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAP. Genes Dev 22: 489-498, 2008.
30. Kruger NJ: The Bradford method for protein quantitation. Methods Mol Biol 32: 9-15, 1994.
31. Chen VC, Gouw JW, Naus CC and Foster LJ: Connexin multi-site phosphorylation: mass spectrometry-based proteomics fills the gap. Biochim Biophys Acta 1828: 23-34, 2013.
32. Jongen WM, Fitzgerald DJ, Asamoto M, et al: Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol 114: 545-555, 1991.
33. Baucum AJ II, Brown AM and Colbran RJ: Differential association of postsynaptic signaling protein complexes in striatum and hippocampus. J Neurochem 124: 490-501, 2013.
34. Fidalgo C, Conejo NM, González-Pardo H and Arias JL: Functional interaction between the dorsal hippocampus and the striatum in visual discrimination learning. J Neurosci Res 90: 715-720, 2012.
35. Xu X, Lu Y and Bie X: Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons. Planta Med 73: 650-654, 2007.
36. Levine AJ, Harris CR and Puzio-Kuter AM: The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway. Oncotarget 3: 1301-1307, 2012.